Other cancers with a relatively high frequency of gene amplification included GI cancers, among which colon cancers, in particular, showed a unique specificity of gene amplification for CDK8 over CDK19, in agreement with the original report [1]. This evidence concerns the gene CDK8 and colonic neoplasm.